Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Congestive Heart Failure
Trial Information
PROTECT Study: A Study of Pro-Brain Natriuretic Peptide (Pro-BNP) Targeted Therapy in Patients with Congestive Heart Failure (CHF) Followed as Outpatients.
Status: Recruiting
Protocol Number: 2003-18
Sponsor: Roche Diagnostics
Company Division: Diagnostic
Official Scientific Title:
Brief Summary: This study will evaluate the effect of standard of care plus proBNP compared with standard of care alone for evaluation and medical management of patients with CHF.
Study Phase: N/A
Study Design / Study Details:
- Purpose:
- Allocation:
- Masking:
- Control:
- Assignment:
- Endpoints:
Study Type:
Interventional
Condition: Congestive Heart Failure
Intervention Type: Diagnostic Test
Intervention Name: proBNP
Primary Outcome:
Key Secondary Outcomes:
Inclusion Criteria:
- adult patients >=21 years of age;
- heart failure;
- hospital admission, emergency department visit, or outpatient treatment escalation for heart failure 6 months before enrollment.
Exclusion Criteria:
- inoperable aortic valvular heart disease;
- cardiac transplantation or revascularization indicated or expected within 6 months;
- severe obstructive or restrictive pulmonary disease;
- coronary revascularization (ie, percutaneous coronary intervention or coronary artery bypass surgery) within previous 3 months;
- severe renal insufficiency.
Gender: Males or Females
Age Limits: Min: Years
Accepts Healthy Volunteers: No
Anticipated Start Date: October, 2005
Trial Registration Date: 06/24/2005
Date Last Updated: 05/07/2008
Link To Trial Results
E-mail: genentechclinicaltrials@druginfo.com
Research Site:
Located in:
Boston, MA 02114-2696
Phone: 888-662-6728 (U.S. Only)
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
